Groupama Asset Managment »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Groupama Asset Managment

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Groupama Asset Managment from 13F filings

Historical chart of Groupama Asset Managment investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Groupama Asset Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Groupama Asset Managment

Quarter filed Position value Share count Share price at filing
2023-12-31 $561k 600k 0.94

More positions owned by Groupama Asset Managment

Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
UnitedHealth (UNH)
NVIDIA Corporation (NVDA)
Motorola Solutions Com New (MSI)
Merck & Co (MRK)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Parker-Hannifin Corporation (PH)
Thermo Fisher Scientific (TMO)
Regeneron Pharmaceuticals (REGN)
Tesla Motors (TSLA)

View all positions for Groupama Asset Managment

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
M&G
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
Leucadia National Corporation
SSI Investment Management
CSS

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1